Fulgent Genetics Inc (FLGT) — Cash Flow Reinvestment Rate
Fulgent Genetics Inc (FLGT) has a Cash Flow Reinvestment Rate of 10.84x as of March 2026, reinvesting $76.90 Million (capex $5.20 Million plus investments $71.70 Million) from operating cash flow of $7.10 Million. Check Fulgent Genetics Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Fulgent Genetics Inc Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Fulgent Genetics Inc across 8 annual periods. Explore Fulgent Genetics Inc (FLGT) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Fulgent Genetics Inc (2016–2024)
Year-by-year capital reinvestment analysis for Fulgent Genetics Inc. For live market cap and broader valuation context, see FLGT company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.69x | $98.67 Million | $21.06 Million | $40.31 Million | ▲ +107.0% |
| 2023 | 2.26x | $61.10 Million | $27.00 Million | $22.21 Million | ▲ +104.8% |
| 2022 | 1.10x | $280.09 Million | $253.52 Million | $18.77 Million | ▲ +22.7% |
| 2021 | 0.90x | $484.74 Million | $538.58 Million | $23.84 Million | ▼ -61.2% |
| 2020 | 2.32x | $326.45 Million | $140.63 Million | $36.51 Million | ▼ -55.9% |
| 2019 | 5.26x | $29.05 Million | $5.52 Million | $1.18 Million | ▼ -19.1% |
| 2017 | 6.51x | $8.66 Million | $1.33 Million | $5.36 Million | ▼ -38.5% |
| 2016 | 10.58x | $46.58 Million | $4.41 Million | $3.79 Million | — |